住院Graves病患者骨代谢状况与131I治疗后转归分析

目的 分析住院Graves病患者骨代谢状况及131I治疗后骨代谢指标的转归。方法 收集315例Graves病住院患者的临床资料,分析骨代谢特点,并与300例健康人群进行病例对照研究。随访131I治疗后1年的Graves病患者60例,分析治疗前后骨代谢指标的变化。结果 与健康对照人群相比,Graves病患者骨转化指标（OCN、P1NP、β-cTX、尿钙/肌酐）增高,骨密度（bone mineral density,BMD）降低,甲状腺激素水平与骨转化指标呈正性相关,与全髋BMD （Z值）呈负性相关,与腰椎、股骨颈BMD （Z值）则未见线性相关。131I治疗后1年的Graves病患者骨转化指标较治...

Full description

Saved in:
Bibliographic Details
Published in复旦学报（医学版） Vol. 44; no. 2; pp. 186 - 191
Main Author 马文杰 吕朝阳 张尧 许桂平 何顺梅 薛孟娟 高键 于明香
Format Journal Article
LanguageChinese
Published 福建省立医院老年科 福州350001%复旦大学附属中山医院内分泌科 上海200032 2017
遵义医学院附属医院内分泌科 遵义563000%复旦大学附属中山医院内分泌科 上海200032
郑州大学第一附属医院老年内分泌科 郑州 450052%复旦大学循证医学中心 上海200032
郑州市第七人民医院内分泌老年病科 郑州450000%复旦大学附属中山医院内分泌科 上海200032%复旦大学附属中山医院内分泌科 上海200032
山东大学齐鲁医院内分泌科 青岛266035%复旦大学附属中山医院内分泌科 上海200032
复旦大学附属中山医院内分泌科 上海200032
Subjects
131I治疗
Graves病
骨代谢
Graves disease
骨代谢
bone metabolism
131I therapy
Graves病
131I治疗
Online AccessGet full text
ISSN1672-8467
DOI10.3969/j.issn.1672-8467.2017.02.010

Cover

More Information
Summary:目的 分析住院Graves病患者骨代谢状况及131I治疗后骨代谢指标的转归。方法 收集315例Graves病住院患者的临床资料,分析骨代谢特点,并与300例健康人群进行病例对照研究。随访131I治疗后1年的Graves病患者60例,分析治疗前后骨代谢指标的变化。结果 与健康对照人群相比,Graves病患者骨转化指标（OCN、P1NP、β-cTX、尿钙/肌酐）增高,骨密度（bone mineral density,BMD）降低,甲状腺激素水平与骨转化指标呈正性相关,与全髋BMD （Z值）呈负性相关,与腰椎、股骨颈BMD （Z值）则未见线性相关。131I治疗后1年的Graves病患者骨转化指标较治疗前明显下降,BMD部分上升。结论 Graves病患者骨转化增快,BMD下降,131I治疗后随着病情好转,高骨转化速率得到遏制,BMD部分恢复。
Bibliography:Graves disease bone metabolism 131I therapy
Objective To analyze the bone metabolism in hospitalized patients with Graves disease and the changes after 131I therapy. Methods The differences of bone metabolism were analyzed between 315 patients with Graves disease and 300 normal controls in a case-control study. The changes in bone turnover markers and BMD levels before and one year after 131I therapy were observed in 60 patients. Results Compared to normal control, bone turnover markers were markly higher and BMD levels were lower in patients with Graves disease. The level of thyroid hormones were positively related to bone turnover markers, while negatively related to total hip BMD （Z-score）. But there was no linear relationship with lumbarand femoral neck BMD （Z-score）. After one year of 131I therapy,bone turnover markers were markly lower than that before treatment, while BMD levels were partly higher than that before treatment. Conclusions In Graves disease patients, bone turnover markers were generally in
ISSN:1672-8467
DOI:10.3969/j.issn.1672-8467.2017.02.010